BAYER AG, Germany's largest drug maker, plans to increase sales in China to more than 100 million euros (US$133.4 million) by introducing new ingredients, formulations and mixtures in the country.

Bayer Crop Science also will invest a further 25 million euros this and next year at its production site in Hangzhou, Zhejiang Province, the German-based company said in an e-mailed statement yesterday.